Norfolk, VA — October 29, 2025 — Synap Biotech Inc™., a biotechnology company pioneering intranasal Nanobody® based therapies for neurological recovery, is pleased to announce the appointment of Dr. Pallavi Tawde as Chief Scientific Officer and Co-Founder.

Norfolk, VA — December 2, 2025 — Synap Biotech, Inc.™, a biotechnology company pioneering intranasal Nanobody®-based therapies to unlock brain repair, is pleased to announce that Prof. Serge Muyldermans, the original pioneer of Nanobody® technology and co-founder of Ablynx N.V., has joined the company’s Scientific Advisory Board (SAB).

Norfolk, VA — January 6, 2026 — Synap Biotech, Inc.™, a biotechnology company pioneering intranasal Nanobody®-based therapies to unlock brain repair, today announced the appointment of Brent A. Buchine, Ph.D. to its Board of Directors.

Norfolk, VA — April 28, 2026 — Synap Biotech, Inc.®, a biotechnology company pioneering intranasal Nanobody®-based therapies to unlock brain repair, is pleased to announce that Dr. Maarten Lansberg, Professor of Neurology at Stanford University and internationally recognized stroke expert, has joined the company’s Scientific Advisory Board.